Pregled bibliografske jedinice broj: 1259451
Long term adverse effects of mild Covid-19 disease on arterial stiffness, and systematic and central hemodynamics: a pre-post study
Long term adverse effects of mild Covid-19 disease on arterial stiffness, and systematic and central hemodynamics: a pre-post study // Journal of clinical medicine (2023) (znanstveni, prihvaćen)
CROSBI ID: 1259451 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Long term adverse effects of mild Covid-19 disease on arterial stiffness, and systematic and central hemodynamics: a pre-post study
Autori
Podrug, Mario ; Koren, Pjero ; Dražić Maras, Edita ; Podrug, Josip ; Čulić, Viktor ; Perissiou, Maria ; Bruno, Rosa Maria ; Mudnić, Ivana ; Boban, Mladen ; Jerončić, Ana
Vrsta, podvrsta
Radovi u časopisima,
znanstveni
Izvornik
Journal of clinical medicine (2023)
Status rada
Prihvaćen
Ključne riječi
arterial stiffness ; central hemodynamics ; COVID-19 ; vascular remodeling ; long COVID-19 syndrome
Sažetak
COVID-19-associated vascular disease complications are primarily associated with endothelial dysfunction ; however, the consequences of disease on vascular structure and function, particularly in the long term (> 7 weeks post-infection), remain unexplored. Individual pre- and post-infection changes in arterial stiffness as well as central and systemic hemodynamic parameters were measured in patients diagnosed with mild COVID-19. As part of in-laboratory observational studies, baseline measurements were taken up to two years before, whereas the post-infection measurements were made 2–3 months after the onset of COVID-19. We used the same measurement protocol throughout the study as well as linear and mixed-effects regression models to analyze the data. Patients (N = 32) were predominantly healthy and young (mean age ± SD: 36.6 ± 12.6). We found that various parameters of arterial stiffness and central hemodynamics—cfPWV, AIx@HR75, and cDBP as well as DBP and MAP—responded to a mild COVID-19 disease. The magnitude of these responses was dependent on the time since the onset of COVID-19 as well as age (pregression_models ≤ 0.013). In fact, mixed-effects models predicted a clinically significant progression of vascular impairment within the period of 2–3 months following infection (change in cfPWV by +1.4 m/s, +15% in AIx@HR75, approximately +8 mmHg in DBP, cDBP, and MAP). The results point toward the existence of a widespread and long-lasting pathological process in the vasculature following mild COVID-19 disease, with heterogeneous individual responses, some of which may be triggered by an autoimmune response to COVID-19.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split,
Sveučilište u Splitu Sveučilišni odjel zdravstvenih studija
Profili:
Ivana Mudnić
(autor)
Viktor Čulić
(autor)
Mladen Boban
(autor)
Ana Jerončić
(autor)
Mario Podrug
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus